This concurrent resolution establishes the congressional budget for the federal government for FY2021, sets forth budgetary levels for FY2022-FY2030, and provides reconciliation instructions for legislation that increases the deficit. The resolution recommends levels and amounts for FY2021-FY2030 for federal revenues, new budget authority, budget outlays, deficits, public debt, debt held by the public, and the major functional categories of spending. It also recommends levels and amounts for Social Security and Postal Service discretionary administrative expenses for the purpose of budget enforcement in the Senate. The resolution includes reconciliation instructions that direct 12 House committees to submit changes in laws within their jurisdictions that will increase the deficit over FY2021-FY2030 by no more than an amount specified for each committee. The committees must submit the legislation to the House Budget Committee by February 16, 2021. (Under current law, reconciliation bills are considered by Congress using expedited legislative procedures that prevent a filibuster and restrict amendments in the Senate.) The resolution establishes reserve funds that allow the chair of the House Budget Committee to revise committee allocations, aggregates, and other budgetary levels to accommodate (1) reconciliation legislation that complies with the instructions in this resolution, and (2) deficit-neutral legislation. It also includes provisions that (1) exempt reconciliation legislation reported by the House Budget Committee under this resolution from the House pay-as-you-go (PAYGO) point of order, and (2) extend a limitation on advance appropriations in the House.
This joint resolution proposes a constitutional amendment prohibiting total outlays for a fiscal year from exceeding total receipts for that fiscal year unless Congress authorizes the excess by a two-thirds vote of each chamber. The prohibition excludes outlays for repayment of debt principal and receipts derived from borrowing. The amendment prohibits total outlays for any fiscal year from exceeding 18% of the gross domestic product of the United States, unless two-thirds of each chamber of Congress provides for a specific increase above this amount. The amendment requires a two-thirds vote of each chamber of Congress to impose a new tax, increase the statutory rate of any tax, or increase the aggregate amount of revenue. It requires a three-fifths vote of each chamber to increase the limit on the debt of the United States. The President must submit an annual budget in which total outlays do not exceed total receipts and 18% of the gross domestic product of the United States. The amendment prohibits a court from ordering a revenue increase to enforce the requirements. Congress may waive specified requirements when a declaration of war is in effect or the United States is engaged in a military conflict that causes an imminent and serious military threat to national security.
This resolution urges the President not to return the United States to the Joint Comprehensive Plan of Action—commonly known as the Iran nuclear deal—unless the agreement is revised and Iran meets specified conditions. Further, the resolution recommends that U.S. sanctions against Iran remain in place until Iran has complied with all elements of a revised agreement.
This resolution expresses the sense of the Senate that the activities of Yevgeniy Prigozhin, his affiliated entities, and the Wagner Group pose a threat to U.S. national security. The resolution calls on the President to work with Congress to develop a strategy to counter these threats. (Prigozhin is a Russian businessman accused of interference in the 2016 U.S. presidential election and the 2018 U.S. midterm elections, and the Wagner Group is a private, Russian paramilitary organization.)
This resolution identifies women's cardiovascular health as an important health care issue and supports gender-specific cardiovascular health research, prevention, and treatment.
This resolution recognizes the contributions of frontline workers and other essential personnel and reaffirms the responsibility of Congress to meet the needs of those workers and the elderly during the COVID-19 (i.e., coronavirus disease 2019) pandemic.
Emergency Care for Veterans During COVID Act This bill requires the Department of Veterans Affairs (VA) to furnish veterans who are enrolled in the VA health care system with emergency treatment at non-VA facilities during the COVID-19 (i.e., coronavirus disease 2019) public health emergency. The VA may not require such veterans to seek authorization for such emergency treatment during this time. The bill also sets forth the payment rates and procedures for such emergency treatment.
Cost Recovery and Expensing Acceleration to Transform the Economy and Jumpstart Opportunities for Businesses and Startups Act or the CREATE JOBS Act This bill allows permanent expensing of qualified property (i.e., property with a recovery period of 20 years or less and that is computer software, water utility property, or film, television, or live theatrical production property). It also modifies depreciation provisions for residential rental property and nonresidential real property. The bill repeals provisions for the amortization of research and experimental expenditures, thus providing for direct expensing of such expenditures.
Federal Actors Lying Should be Eliminated Act or the FALSE Act This bill requires the removal of federal employees who knowingly and willfully make false statements to the government, misappropriate funds, or enter inaccurate information into the government's public spending website (USAspending.gov).
Pandemic Emergency Manufacturing Act of 2021 This bill establishes within the Department of Health and Human Services (HHS) an Emergency Office of Manufacturing for Public Health to manufacture and distribute medical products to address COVID-19 (i.e., coronavirus disease 2019) or medical products that are on shortage or vulnerable to shortage. The office must (1) obtain the rights to manufacture the applicable medicines, ingredients, diagnostic tests, medical devices, personal protective equipment, and supplies; (2) manufacture or contract to manufacture such items; and (3) construct, or enter into construction contracts for, facilities to manufacture certain medicines, such as vaccines. HHS may issue involuntary licenses allowing the office to make, use, sell, import, or export an invention related to an applicable drug, biological product, or device and to use clinical trial data and confidential information. Such a license must provide the rights holder with reasonable compensation. The office must (1) provide such COVID-19 products at no cost to federal, state, local, and other health programs and certain domestic health care providers and suppliers; (2) offer COVID-19 products at cost to other commercial and international entities; and (3) offer other medical products to entities at a fair price, based on cost and other considerations. The office shall prioritize the manufacture of certain COVID-19 products and meet manufacturing timelines specified in the bill.
Emergency Assistance for Rural Water Systems Act of 2021 This bill allows, and provides funds for, the Department of Agriculture (USDA) to provide grants and loans, as well as loan forgiveness, modification, and refinancing, to rural water, wastewater, or waste disposal facilities. Specifically, USDA may provide such assistance for purposes of ensuring public health, safety, and order and to address financial hardships, in particular those due to the COVID-19 (i.e., coronavirus disease 2019) public health emergency.
Secure Data and Privacy for Contact Tracing Act of 2021 This bill establishes grants for state, tribal, and territorial health departments to incorporate digital contact tracing technology in COVID-19 (i.e., coronavirus disease 2019) contact tracing programs. The Centers for Disease Control and Prevention must award the grants. Any technology developed or procured with these grants must meet privacy, security, and other conditions. Grantees that acquire technology that does not meet these conditions lose eligibility for this, and future, funding for COVID-19 contact tracing technology. In addition, federal privacy standards for personal health information expressly apply to information transmitted or maintained by grant-funded programs. Current law restricts the use and disclosure of personal health information by health care providers, health plans, health clearinghouses, and their business associates. However, there is an exception to these standards for information used by, or disclosed to, a public health authority. The bill also prohibits the use of data derived from the contact tracing technology in legal proceedings or for immigration enforcement. The Government Accountability Office must evaluate this program.
